Citigroup’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$159K Buy
12,990
+6,774
+109% +$83.1K ﹤0.01% 3445
2025
Q1
$68.4K Buy
+6,216
New +$68.4K ﹤0.01% 4016